E-cadherin, p16, MGMT, and DAPK hypermethylation was analyzed in 253 laryngeal and hypopharyngeal cancer patients, highlighting the high frequency of this event, although no correlation was detected with mortality or second primary cancer occurrence [147]. Here, CDKN2A is linked to cancer.